IP Library Granted Patent US 10,510,438
Granted Patent B2
US 10,510,438 · App. 15/644,603 · Granted Dec 17, 2019

System and method for building intuitive clinical trial applications

Inventors: Jeff Frazier (Tustin, CA); John Reites (Tustin, CA); Sean Vassilaros (Tustin, CA)
Assignee: Definitive Media Corp.
G16H10/20G16H10/60G06F21/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,510,438
App. No.
15/644,603
Filed
Jul 7, 2017
Granted
Dec 17, 2019
Kind
B2
Art Unit
3626
USPC
705/2
Abstract

The present invention allows clinical trial organizers to operate a platform for creating trial specific custom mobile applications at a price point that would not be possible if the application were created by programmers on a trial-by-trial basis. The invention shortens build time by creating a hierarchy of questions that changes the next question posed to the user based upon their answer to a previous question thereby reducing the number of questions the user must answer while providing the application creation platform with the detailed information relevant to a specific clinical trial. The platform uses a simulation builder that provides a test version of the application to the user mobile device during the application creation process thereby allowing the user to see the layout of the application as they progress through the building process. While building the application, the user can create a simulated version of the application in real time deliver the same to the mobile device of the user. The system creates a handshaking process that allows the user to create annotations and/or edits in the simulated application that are communicated back to the building platform. Changes made in the simulated application will affect the landing page the user sees when returning to the building platform. The system will collect usability data from a clinical trial application on a plurality of trial subject and trial organizer mobile devices. The system can measure variables such as time on page, misentries, and missed selections of icons to determine common trouble spots for users. That data may be used to redesign the interface or process flow of the application to optimize usability.

Claims (36)

1. A method for remote clinical trial organization, the method comprising;

receiving a response to at least a first question from a hierarchy of questions designed to identify one or more elements necessary to complete a clinical trial in an application-based testing environment;

positing at least a second question from the hierarchy of questions, the second question based on the received response to the at least first question, whereby the collective responses to the questions are used to access the identified elements from a database of elements, wherein the database is updated with modules and applications related to application self-construction;

constructing an application for the clinical trial based on the collective responses, the application constructed as an arrangement of the identified elements and including any clinical and consumer medical monitoring devices necessary for the trial;

processing data collected from a trial subject utilizing the application for the clinical trial and any corresponding clinical and consumer medical monitoring devices, the data processed at a cloud-based server environment including at least one server from a server farm and that stores and instantiates a software platform that organizes the clinical trial through authoring of the application and that further operates in conjunction with the clinical trial; and

modifying the application in real-time responsive to the processed data collected from the trial subject, wherein modifying the application includes modifying the arrangement of the identified elements within the application.

2. The method of claim 1 , further comprising executing a real-time simulation of the application before launching the application; and collecting data from one or more trial subjects utilizing the application during the real-time simulation.

3. The method of claim 2 , wherein modifying the application is based on the real-time simulation and occurs prior to launching the application.

4. The method of claim 1 , wherein modifying the application includes modifying a variable.

5. The method of claim 4 , wherein the variable is time.

6. The method of claim 4 , wherein the variable is an option for user entry.

7. The method of claim 4 , wherein the variable is an option for user selection.

8. The method of claim 4 , wherein modifying the variable is based on processed data that includes time.

9. The method of claim 4 , wherein modifying the variable is based on processed data that includes a user entry.

10. The method of claim 4 , wherein modifying the variable is based on processed data that includes a user selection.

11. The method of claim 4 , further comprising identifying a user trouble spot, wherein modifying the application occurs after identifying the user trouble spot.

12. The method of claim 4 , wherein modifying the clinical trial application includes redesigning at least one user interface.

13. The method of claim 4 , wherein modifying the application includes modifying a process flow.

14. The method of claim 4 , wherein modifying the application includes changing usability of the application.

15. The method of claim 1 , further comprising displaying the identified elements on a user device prior to constructing the application, wherein the arrangement is modifiable based on input received at the user device.

16. The method of claim 1 , wherein the elements stored in the database of elements include at least one of patient data collection module, cosmetic features, application content, layout features, study question, login, prompt, and list of clinical and consumer medical monitoring devices.

17. The method of claim 1 , wherein at least one of the identified elements is configured to interface with at least one medical monitoring device.

18. The method of claim 1 , further comprising identifying that one or more elements are missing from the application, and presenting a recommendation regarding introduction of the identified elements into the application.

19. The method of claim 1 , wherein the constructed application is accessible through a plurality of different portals each specific to a different user type.

20. A system for remote clinical trial organization, the system comprising:

a user device that provides a prompt to build a clinical trial application in accordance with one or more clinical trial requirements;

a software platform that is stored on and instantiates in a cloud-based server environment including at least one server from a server farm, the instantiation responsive to the prompt from the user device to build the clinical trial application including a selection of clinical and consumer medical monitoring devices necessary for a clinical trial, whereupon the software platform:

executes to posit a series of iterative questions from a hierarchy of questions that drive the building of the clinical trial application in accordance with the clinical trial requirements, each response to each question from the series of iterative questions determining a next question in the series,

identifies one or more elements from a database of elements based on collective responses to the series of questions, wherein the software platform is updated with modules and applications related to application self-construction, and

constructs the clinical trial application based on the collective responses, the clinical trial application constructed as an arrangement of the identified elements;

and

one or more additional user devices not involved in building the clinical trial application and that exchange data with the software platform concerning execution of the clinical trial application, wherein the instantiated software platform is further executable to modify the clinical trial application responsive to the information exchanges with at least one of the additional user devices, wherein the instantiated software platform modifies the application by modifying the arrangement of the identified elements within the application.

21. The system of claim 20 , wherein the instantiated software platform constructs the clinical trial application in real-time.

22. The system of claim 21 , wherein the instantiated software platform is further executable to simulate execution of the clinical trial application.

23. The system of claim 22 , wherein the simulation occurs in real-time.

24. The system of claim 21 , wherein the user device further provides data to the software platform concerning execution of the clinical trial application.

Assignments (4)
SECURITY INTEREST Recorded Jul 25, 2023
From: DEFINITIVE MEDIA CORP. D/B/A THREAD
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 064377/0920 →
PATENT SECURITY AGREEMENT Recorded Dec 19, 2019
From: DEFINITIVE MEDIA CORP.
To: KEYBANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 051376/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2019
From: REITES, JOHN; VASSILAROS, SEAN
To: DEFINITIVE MEDIA CORP. (DBA THREAD)
Reel/Frame 049815/0354 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2019
From: FRAZIER, JEFF
To: DEFINITIVE MEDIA CORP. (DBA THREAD)
Reel/Frame 049138/0801 →
Continuity (1)
Related Publication 20190012434A1 · Jan 10, 2019
Cited By (6)
US 12,230,406 US 12,248,388 US 12,248,389 US 12,282,408 US 12,354,714 US 12,487,901